HB 2107

  • Oklahoma House Bill
  • 2023 Regular Session
  • Introduced in House Mar 13, 2023
  • Passed House Mar 09, 2023
  • Senate
  • Governor

Controlled dangerous substances; authorizing certain scientific research and clinical trials related to psilocybin and psilocyn; requiring registration; providing certain immunities; effective date.

Votes


No votes to display

Actions


Mar 29, 2023

Senate

Second Reading referred to Health and Human Services Committee then to Appropriations Committee

Mar 14, 2023

Senate

Coauthored by Representative Munson

Senate

Coauthored by Representative Rosecrants

Mar 13, 2023

Senate

First Reading

House

Engrossed, signed, to Senate

Mar 09, 2023

House

Third Reading, Measure passed: Ayes: 66 Nays: 32

House

Referred for engrossment

House

Title stricken

House

General Order

House

Coauthored by Representative(s) Talley, Hefner, Deck

House

Authored by Senator Brooks (principal Senate author)

House

Amended

Feb 15, 2023

House

CR; Do Pass, amended by committee substitute Alcohol, Tobacco and Controlled Substances Committee

Feb 07, 2023

House

Second Reading referred to Alcohol, Tobacco and Controlled Substances

Feb 06, 2023

House

First Reading

House

Authored by Representative Pae

Bill Text

Bill Text Versions Format
Introduced PDF
House Committee Substitute PDF
Floor (House) PDF
Engrossed PDF
1 Floor Amendment by MARTINEZ (UNTIMELY FILED) PDF
HB2107 FULLPCS1 DANIEL PAE-TJ.PDF PDF

Related Documents

Document Format
House Committee Report PDF

Sources

Data on Open States is updated periodically throughout the day from the official website of the Oklahoma Legislature.

If you notice any inconsistencies with these official sources, feel free to file an issue.